Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by LaserStock29on Feb 01, 2020 12:09pm

148 Views

Post# 30629162

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA IND NEWS!!!!!!!!!!!!!!!!!!

Yep so long as the IND delay doesn't push the Q3 2020 treatment of US patients so we can have the start of 3 month usa data by christmas and 6 month by no later than mid- end q1 2021. See how fast you can just nudge the timeline kicking it down the road. Glad to hear the TMO hospitals are being brought up to speed ahead of it.

Yajne wrote: That's how it should work IMO. Let's hope that they're being as proactive during this IND 'waiting time' as has been speculated in some recent posts.

Quattro74 wrote:
Having that TMO agreement in the US should mean a rapid start, once IND is approved. :-)